Aducanumab
| Specifications | |
|---|---|
| CAS Number: | 1384260-65-4 |
| Synonyms: | BIIB037 |
Description
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease (AD).
Price
190,00 €
